Gout (Chronic Refractory) Market Assessment 2024 Featuring 15 Companies and 20 Key Drugs - Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
September 30, 2024 05:35 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Gout (Chronic Refractory) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has...
Gout Opportunity Assessment and Forecast Report 2022-2032: Focus on 7 Major Markets - United States, France, Germany, Italy, Spain, UK, and Japan
January 23, 2024 08:28 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Gout - Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.The prevalence of gout is on the rise, keeping...
DelveInsight Estimates a Promising Gout Pipeline Owing to an Expected Entry of Novel Therapeutic Agents
August 31, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Aug. 31, 2021 (GLOBE NEWSWIRE) -- DelveInsight Estimates a Promising Gout Pipeline Owing to an Expected Entry of Novel Therapeutic Agents Around 40+ key companies are developing...
United States Gout Market and Competitive Landscape Report 2017-2019 & 2020-2026
January 19, 2021 04:23 ET
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Gout Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Gout Market and Competitive Landscape...
United States Gout Industry Outlook 2020-2025 - Pipeline, Epidemiology, Key Products, Market Valuations & Forecast, Drugs Sales and Market Shares
September 04, 2020 08:14 ET
|
Research and Markets
Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "US Gout Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive...